Catalyst Wire Dossier Catalyst Wire Dossier

Olaparib

Olaparib · AstraZeneca
Drug timelines are a Plus or Pro feature.

156 regulatory and trial events tracked for Olaparib, covering 2012-12-10 to 2026-06-09. Get the full timeline:

Most recent: Clinical Trial Update: Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients [Phase 3]

See pricing